Community-Engaged Sleep Intervention for School-Aged Children With Autism Spectrum Disorder
Community-Engaged Behavioral Sleep and Circadian Intervention for School-Aged Children With Autism Spectrum Disorder
1 other identifier
interventional
50
1 country
1
Brief Summary
As many as 78% of children with autism spectrum disorder (ASD) have significant sleep disturbance compared to 20% of children without ASD. In children with ASD, shorter sleep duration and lower sleep efficiency, are associated with disruptive behavior, anxiety, and increased parental stress. Therefore, multiple sleep dimensions (B-SATED: behaviors, satisfaction, alertness, timing, efficiency, duration) are appropriate therapeutic targets to improve daytime behavioral functioning and other psychosocial outcomes. The primary objective is to evaluate the implementation of a modification of a behavioral sleep and circadian intervention to improve multiple sleep dimension in school-age children with ASD. To accomplish this objective, a 12-week, randomized pilot study will be conducted to assess the feasibility, acceptability, and preliminary efficacy of a modified behavioral sleep and circadian intervention with up to 50 school-age children with ASD, to determine whether the intervention improves multiple dimensions of sleep (B-SATED: behaviors, satisfaction, alertness, timing, efficiency, duration), daytime behavior, quality of life, parental stress, and parental self-efficacy. This modified intervention is guided by the Pediatric Sleep Health Framework that encourages improvement in six pediatric sleep dimensions (B-SATED): sleep behaviors; parents' satisfaction with child sleep; daytime alertness/sleepiness; appropriate timing of sleep within the 24-hour day; sleep efficiency, i.e., ease of falling and staying asleep; and sleep duration. The Sadeh and Anders Sleep-Wake Regulation Model was used to propose linkages between outcomes. The investigators hypothesize that parents implementing the modified intervention will improve the primary outcome (clinician- and parent-ratings of child sleep) and secondary child (sleep dimensions, daytime behavior, quality of life) and parent outcomes (stress and self-efficacy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedStudy Start
First participant enrolled
August 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
December 22, 2025
December 1, 2025
11 months
May 19, 2025
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Improvement Scale of the Clinical Global Impressions Scale (CGI-I)
The improvement scale of Clinical Global Impression (CGI-I) Scale will be used to evaluate treatment-related improvement. The CGI-Improvement scale is rated by a clinician on a scale of 1 to 7, with 1 representing "very much improved" and 7 representing "very much worse." The CGI-Improvement scale (Scores 1 "very much improved" or 2 "much improved") will be used to identify a positive response to treatment.
Baseline, Post-Intervention (Week 12), and Follow Up (Week 24)
Change in the Pediatric Autism Insomnia Rating Scale (PAIRS)
The PAIRS is a parent rating of insomnia and sleep-related impairments over the past two weeks in children with ASD age 3 to 12 years. The PAIRS is a single-factor measure comprising 21 items that assess difficulties with falling and/or staying asleep, as well as the impact of sleep problems on the child and the family. Items are scored: 0 (mild = not present, not a problem) to 3 (severe = frequent and a major problem). Higher scores indicate greater severity.
Baseline, Post-Intervention (Week 12), and Follow Up (Week 24)
Secondary Outcomes (6)
Change in Child Sleep Dimensions Composite Score
Baseline, Post-Intervention (Week 12)
Change in Child Daytime Behavior
Baseline, Post-Intervention (Week 12), and Follow Up (Week 24)
Change in Child Health-Related Quality of Life
Baseline, Post-Intervention (Week 12), and Follow Up (Week 24)
Change in Parental Stress
Baseline, Post-Intervention (Week 12), and Follow Up (Week 24)
Change in Parental Sense of Competence
Baseline, Post-Intervention (Week 12), and Follow Up (Week 24)
- +1 more secondary outcomes
Study Arms (2)
Modified Sleep and Circadian Intervention
EXPERIMENTALUp to 50 children will be randomly assigned (1:1) to the modified sleep and circadian intervention or enhanced usual care for 12 weeks.
Enhanced Usual Care Control Condition
ACTIVE COMPARATORUp to 50 children will be randomly assigned (1:1) to the modified sleep and circadian intervention or enhanced usual care for 12 weeks.
Interventions
The modified sleep and circadian intervention has 5 individual sessions that will be delivered via Zoom to parents over 12 weeks and consists of 4 cross-cutting modules (functional analysis, goal setting, motivational interviewing, sleep education), 5 core sessions, and 7 optional modules that are delivered based on personalized treatment goals. The intervention format is as follows: (1) 60-minute session with consultation on setting goals and developing an action plan to improve sleep timing, quantity, and regularity; (2) 5-minute weekly follow-ups and a 3-night sleep diary; and (3) four 30-45-minute booster sessions every 3 weeks. Child attendance is optional.
Enhanced Usual Care (EUC) is an active comparison treatment balanced for time and attention. Participants will be asked to maintain their typical sleep schedules. EUC sessions will review the interrelationships between stress, diet, health, exercise, and behavior, with a sleep education portion \< 10 minutes and no encouragement to change behavior. EUC sessions will be used to establish rapport and promote study retention. EUC participants will not complete weekly sleep diaries. At the end of Week 12, EUC participants will receive a 1-hour optional Zoom session with the PI on sleep education.
Eligibility Criteria
You may qualify if:
- Children 6-12 years with a clinical diagnosis of ASD defined by the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition and corroborated by the Social Communication Questionnaire-lifetime score of ≥ 15.
- Child must have ≥ 1 poor sleep health dimensions (B-SATED).
- Child is not currently participating in any sleep-related interventions.
- Child has not had any medication changes within the past month that interfere with sleep.
- If present, the child must have a treated OSA (mild or less) diagnosis and willingness to continue treatment (≥80% adherence).
- Parent must be an adult legal guardian proficient in English.
You may not qualify if:
- Children with an untreated complex medical condition that interferes with sleep (e.g., epilepsy, nocturnal seizures).
- Children with moderate to severe OSA.
- Unable to complete protocol (e.g., serious behavioral concerns, bereavement, currently homeless).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Case Western Reserve Universitylead
- American Academy of Sleep Medicinecollaborator
- National Institutes of Health (NIH)collaborator
- National Center for Advancing Translational Sciences (NCATS)collaborator
- University Hospitals Cleveland Medical Centercollaborator
Study Sites (1)
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Megan L Wenzell, PhD
Case Western Reserve University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A trained researcher, masked to group assignment, will administer the primary outcome as an independent evaluator. Since this is a pilot study, the PI will deliver the intervention to allow for real-time adjustments and optimal quality control.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 19, 2025
First Posted
June 6, 2025
Study Start
August 27, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share